Multiple antiviral activities of cyanovirin-N: Blocking of human immunodeficiency virus type 1 gp120 interaction with CD4 and coreceptor and inhibition of diverse enveloped viruses

Journal of Virology

Volumn 74, Issue 10, 2000, Pages 4562-4569

  Dey, Barna ^a   Lerner, Danica L ^b   Lusso, Paolo ^c   Boyd, Michael R ^d   Elder, John H ^b   Berger, Edward A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BACTERIAL PROTEIN; CD4 ANTIGEN; CHEMOKINE RECEPTOR; CYANOVIRIN N; GLYCOPROTEIN GP 120; LYMPHOCYTE ANTIGEN RECEPTOR; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG POTENCY; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; HUMAN IMMUNODEFICIENCY VIRUS 1; MEASLES VIRUS; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR DOWN REGULATION; VIRUS ENVELOPE;

ANIMALS; ANTI-HIV AGENTS; ANTIGENS, CD4; ANTIVIRAL AGENTS; BACTERIAL PROTEINS; CARRIER PROTEINS; CATS; CELL LINE; HERPESVIRUS 6, HUMAN; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; MEASLES VIRUS; MEMBRANE FUSION; MICE; RECEPTORS, CCR5; VIRAL ENVELOPE PROTEINS;

EID: 0033997468     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.10.4562-4569.2000     Document Type: Article

References (34)

1. Alexander, W. A., B. Moss, and T. R. Fuerst. 1992. Regulated expression of foreign genes in vaccinia virus under the control of bacteriophage T7 RNA polymerase and the Escherichia coli lac repressor. J. Virol. 66:2934-2942.
2. Alkhatib, G., C. C. Broder, and E. A. Berger. 1996. Cell-type-specific fusion cofactors determine human immunodeficiency virus type 1 tropism for T-cell lines versus primary macrophages. J. Virol. 70:5487-5494.
3. Berger, E. A., P. M. Murphy, and J. M. Farber. 1999. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease. Annu. Rev. Immunol. 17:657-700.
4. Bewley, C. A., K. R. Gustafson, M. R. Boyd, D. G. Covell, A. Bax, G. M. Clore, and A. M. Gronenborn. 1998. Solution structure of cyanovirin-N, a potent HIV-inactivating protein. Nat. Struct. Biol. 5:571-578.
5. Boyd, M. R., K. R. Gustafson, J. B. McMohan, R. H. Shoemaker, B. R. O'Keefe, T. Mori, R. J. Gulakowski, L. Wu, M. I. Rivera, C. M. Laurencot, M. J. Currens, I. J. H. Cardellina, J. R. W. Buckheit, P. L. Nara, L. K. Pannell, I. R. C. Sowder, and L. E. Henderson. 1997. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that hinds viral surface envelope glycoprotein gp120: potential application to microbicide development. Antimicrob. Agents Chemother. 41:1521-1530.
6. Brelot, A., N. Heveker, K. Adema, M. J. Hosie, B. Willet, and M. Alizon. 1999. Effect of mutations in the second extracellular loop of CXCR4 on its utilization by human and feline immunodeficiency viruses. J. Virol. 73:2576-2586.
7. Broder, C. C., and E. A. Berger. 1995. Fusogenic selectivity of the envelope glycoprotein is a major determinant of human immunodeficiency virus type 1 tropism for CD4+ T-cell lines vs. primary macrophages. Proc. Natl. Acad. Sci. USA 92:9004-9008.
8. Broder, C. C., D. S. Dimitrov, R. Blumenthal, and E. A. Berger. 1993. The block to HIV-1 envelope glycoprotein-mediated membrane fusion in animal cells expressing human CD4 can be overcome by a human cell component(s). Virology 193:483-491.
9. Combadiere, C., K. Salzwedel, E. D. Smith, H. L. Tiffany, E. A. Berger, and P. M. Murphy. 1998. Identification of CX3CR1. A chemotactic receptor for the human CX3C chemokine fractalkine and a fusion coreceptor for HIV-1. J. Biol. Chem. 273:23799-23804.
10. Doms, R. W., R. Blumenthal, and B. Moss. 1990. Fusion of intra-and extracellular forms of vaccinia virus with the cell membrane. J. Virol. 64: 4884-4892.
11. Dorig, R. E., A. Marcil, A. Chopra, and C. D. Richardson. 1993. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75: 295-305.
12. Esser, M. T., T. Mori, I. Mondor, Q. J. Sattentau, B. Dey, E. A. Berger, M. R. Boyd, and J. D. Lifson. 1999. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120. J. Virol. 73:4360-4371.
13. Fuerst, T. R., E. G. Niles, F. W. Studier, and B. Moss. 1986. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA 83: 8122-8126.
14. Gong, S. C., C. F. Lai, and M. Esteban. 1990. Vaccinia virus induces cell fusion at acid pH and this activity is mediated by the N-terminus of the 14-kDa virus envelope protein. Virology 178:81-91.
15. Kwong, P. D., R. Wyatt, J. Robinson, R. W. Sweet, J. Sodroski, and W. A. Hendrickson. 1998. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393:648-659.
16. Lerner, D. L., C. K. Grant, A. de Parsaval, and J. H. Elder. 1998. FIV infection of IL-2 dependent and independent feline lymphocyte lines: host cell range distinctions and specific cytokine upregulation. Vet. Immunol. Immunopathol. 65:277-297.
17. - T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1. J Virol. 69:3712-3720.
18. Mariner, J. M., J. B. McMohan, B. R. O'Keefe, K. Nagashima, and M. R. Boyd. 1998. The HIV-inactivating protein, cyanovirin-N, does not block gp120-mediated virus-to-cell binding. Biochem. Biophys. Res. Commun. 248: 841-845.
19. Mori, T., K. R. Gustafson, L. K. Pannell, R. H. Shoemaker, L. Wu, J. B. McMohan, and M. R. Boyd. 1998. Recombinant production of cyanovirin-N, a potent human immunodeficiency virus-inactivating protein derived from a cultured cyanobacterium. Protein Expression Purif. 12:151-158.
20. Nussbaum, O., C. C. Broder, and E. A. Berger. 1994. Fusogenic mechanisms of enveloped-virus glycoproteins analyzed by a novel recombinant vaccinia virus-based assay quantitating cell fusion-dependent reporter gene activation. J. Virol. 68:5411-5422.
21. Nussbaum, O., C. C. Broder, B. Moss, L. B. Stern, S. Rozenblatt, and E. A. Berger. 1995. Functional and structural interactions between measles virus hemagglutinin and CD46. J. Virol. 69:3341-3349.
22. Phillips, T. R., R. L. Talbott, C. Lamont, S. Muir, K. Lovelace, and J. H. Elder. 1990. Comparision of two host cell range variants of feline immunodeficiency virus. J. Virol. 64:4605-4613.
23. Poeschla, E. M., and D. J. Looney. 1998. CXCR4 is required by a nonprimate lentivirus: heterologous expression of feline immunodeficiency virus in human, rodent, and feline cells. J. Virol. 72:6858-6866.
24. Salahuddin, S. Z., D. V. Ablashi, P. D. Markham, S. F. Josephs. S. Sturzenegger, M. Kaplan, G. Halligan, P. Biberfeld, F. Wong-Staal, B. Kramarsky, et al. 1986. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234:596-601.
25. Salzwedel, K., E. Smith, B. Dey, and E. Berger. 2000. Sequential CD4/ coreceptor interactions in human immunodeficiency virus type 1 Env function: soluble CD4 activates Env for coreceptor-dependent fusion and reveals blocking activities of antibodies against cryptic conserved epitopes on gp120. J. Virol. 74:326-333.
26. Santoro, F., P. E. Kennedy, G. Locatelli, M. S. Malnati, E. A. Berger, and P. Lusso. 1999. CD46 is a cellular receptor for human herpesvirus 6. Cell 99: 817-827.
27. Talbott, R. L., E. E. Sparger, K. M. Lovelace, W. M. Fitch, N. C. Pedersen, P. A. Luciw, and J. H. Elder. 1989. Nucleotide sequence and genomic organization of feline immunodeficiency virus. Proc. Natl. Acad. Sci. USA 86:5743-5747.
28. Trkola, A., T. Dragic, J. Arthos, J. M. Binley, W. C. Olson, G. P. Allaway, C. Cheng-Mayer, J. Robinson, P. J. Maddun, and J. P. Moore. 1996. CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR5. Nature 384:184-187.
29. Trkola, A., M. Purtscher, T. Muster, C. Ballaun, A. Buchacher, N. Sullivan, K. Srinivasan, J. Sodroski, J. P. Moore, and H. Katinger. 1996. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J. Virol. 70: 1100-1108.
30. Willet, B. J., M. J. Hosie, J. C. Neil, J. D. Turner, and J. A. Hoxie. 1997. Commun mechanism of infection by lentiviruses. Nature 385:587.
31. Willet, B. J., L. Picard, M. J. Hoxie, J. D. Turner, K. Adema, and P. R. Clapham. 1997. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses. J. Virol. 71:6407-6415.
32. Wu, L., N. P. Gerard, R. Wyatt, H. Choe, C. Parolin, N. Ruffing, A. Borsetti, A. A. Cardoso, E. Desjardin, W. Newman, C. Gerard, and J. Sodroski. 1996. CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5. Nature 384:179-183.
33. Wyatt, R., and J. Sodroski. 1998. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. Science 280:1884-1888.
34. Yang, F., C. A. Bewley, J. M. Louis, K. R. Gustafson, M. R. Boyd, A. M. Gronenborn, G. M. Clore, and A. Wlodawer. 1999. Crystal structure of cyanovirin-N, a potent HIV-inactivating protein, shows unexpected domain swapping. J. Mol. Biol. 288:403-412.